Drug profile · INN
tasimelteon
HETLIOZ
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
tasimelteon (HETLIOZ) is an FDA-listed pharmaceutical active ingredient. Associated with Vanda Pharmaceuticals Netherlands B.V.. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12049457
Highly purified pharmaceutical grade tasimelteon
granted -
US 11759446
Liquid tasimelteon formulations and methods of use thereof
granted -
US 11760740
Highly purified pharmaceutical grade tasimelteon
granted -
US 11566011
Highly purified pharmaceutical grade tasimelteon
granted -
US 11203581
Highly purified pharmaceutical grade tasimelteon
granted -
US 11202770
Liquid tasimelteon formulations and methods of use thereof
granted -
US 10829465
Highly purified pharmaceutical grade tasimelteon
granted -
US 10611744
Highly purified pharmaceutical grade tasimelteon
granted
Frequently asked questions
What is tasimelteon?
tasimelteon (HETLIOZ) is an FDA-listed pharmaceutical active ingredient. Associated with Vanda Pharmaceuticals Netherlands B.V.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tasimelteon?
HETLIOZ is a marketed brand name for tasimelteon. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tasimelteon?
tasimelteon has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.